What are the recommendations of the ADA Standards of Medical Care in Diabetes?

Updated: Jun 27, 2020
  • Author: Romesh Khardori, MD, PhD, FACP; Chief Editor: George T Griffing, MD  more...
  • Print

The 2018 edition of the ADA’s Standards of Medical Care in Diabetes recommends that a glucose-lowering medication with proven cardiovascular and/or mortality-reducing benefit be used to treat patients with type 2 diabetes who have established atherosclerotic cardiovascular disease and in whom lifestyle modification and metformin use have failed to achieve glycemic targets. [354, 355, 356, 357, 358, 359, 360, 361, 362, 363, 364, 365, 366, 367, 368, 369, 370]

It is also recommended that children and adolescents who, along with being overweight or obese, have at least one additional diabetes risk factor be screened for prediabetes and type 2 diabetes.

Another recommendation urges pregnant women with preexisting type 1 or type 2 diabetes to consider taking a low daily aspirin dose beginning at the end of the first trimester in order to lower their preeclampsia risk.

The recommendations continue to define hypertension in diabetes as 140/90 mm Hg or greater rather than considering a value of 130/80 mm Hg to represent stage 1 hypertension, as organizations such as the American College of Cardiology and the American Heart Association now do.

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!